Hongxun, a specialized enterprise dedicated to the R&D of high-performance hemodialysis collection products, is currently ...

A systematic review of randomized acute heart failure trials finds that short-term weight loss shows only a directional, ...

ULTRA-Peds Registry evaluated 91 pediatric patients across seven leading children's hospitals, providing important clinical evidence which the Company intends to use to support its proposed label ...

The diagnosis of traumatic brain injury (TBI) remains heavily constrained by the limitations of conventional imaging ...

Jennifer Flythe, MD, MPH, discusses individualizing dialysis volume management and why guideline-directed therapy use lags in advanced CKD.

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the ...

A published case report describes how stage-specific integrated nursing management supported a 39-year-old woman's transition ...

A hypothesis-generating pilot study found that bedside internal jugular vein (IJV) ultrasound was feasible, with several IJV ...

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ...

Sodium bicarbonate is an antacid medication that can help treat people with chronic kidney disease (CKD) who develop metabolic acidosis, a condition where too much acid builds up in the body.

Since its inception as an adjunct to cardiopulmonary bypass in the late 1980s, modified ultrafiltration (MUF) has evolved into a pivotal strategy for mitigating the systemic inflammatory response and ...